Rotavirus morphogenesis involves the budding of subviral particles through the rough endoplasmic reticulum (RER) membrane of infected cells. During this process, particles acquire the outer capsid proteins and a transient envelope. Previous immunocytochemical and biochemical studies have suggested that a rotavirus nonstructural glycoprotein, NS28, encoded by genome segment 10, is a transmembrane RER protein and that about 10,000 Mr of its carboxy terminus is exposed on single-shelled particles was obtained by cosedimentation of preformed receptor-ligand complexes through sucrose gradients. The domain on NS28 responsible for binding also was characterized. Reduced binding of single-shelled particles to membranes was seen with membranes treated with (i) a monoclonal antibody previously shown to interact with the C terminus of NS28, (ii) proteases known to cleave the C terminus of NS28, and (iii) the Enzymobead reagent. VP6 on single-shelled particles was suggested to interact with NS28 because (i) a monoclonal antibody to the subgroup I epitope on VP6 reduced particle binding, (ii) a purified polyclonal antiserum raised against recombinant baculovirus-produced VP6 reduced ligand binding, and (iii) a monoclonal antibody to a conserved epitope on VP6 augmented ligand binding. These experimental data provide support for the hypothesized receptor role of NS28 before the budding stage of rotavirus morphogenesis.
Rotaviruses are widely recognized as the major etiologic agents of infantile viral gastroenteritis throughout the world. However, little work has been done on the molecular mechanism(s) of rotavirus morphogenesis. Understanding the details of assembly of this virus is significant because this unique step in replication could be an excellent target for the design of methods to control virus replication. In addition, rotaviruses are useful models to study the mechanisms that control specific protein transport into the endoplasmic reticulum (ER).
Rotavirus-infected cells contain several distinct morphologic features. Mature, 70-nm, infectious double-shelled (ds) particles are found in the cisternae of the rough endoplasmic reticulum (RER) (1, 7, 23, 33, 37) . Cytoplasmic, non-membrane-bound viroplasms, seen adjacent to the RER membrane, appear to be the sites of assembly of the 37-nm core and the 55-nm single-shelled (ss) particles (1, 35) . Particles bud through the RER membrane, and transient enveloped particles are observed in the lumen of the ER. These particles have been inferred to be intermediates in virus morphogenesis because they accumulate in the RER lumen when virus-infected cells are grown in the presence of tunicamycin (22, 36, 40) . This enveloped intermediate stage has been hypothesized to result from the budding of subviral particles (possibly ss particles) through the RER membrane (15, 22) . Glycosylation of the rotavirus nonstructural glyco-protein NS28 was recognized to be important in the budding and maturation process when enveloped particles were shown to accumulate in tunicamycin-treated cells infected with a variant (clone 28) of SAil that codes for nonglycosylated VP7 (14, 36) .
Previous studies by our laboratory and others have demonstrated that NS28 is a transmembrane glycoprotein in the RER membrane (12, 27) . Ultrastructural immunocytochemical electron microscopy (38) and recent topographic studies (3, 5) also have indicated that a large C-terminal domain of NS28 (at least 10,000 Mr) is exposed on the cytoplasmic side of the RER membrane. We have hypothesized that this domain of NS28 could serve as a receptor prior to the budding process of ss particles through the membrane (2) . This study reports the development and use of an in vitro binding system to examine whether ss particles bind specifically to RER membranes containing NS28, and it provides direct evidence that NS28 acts as a receptor in the RER membrane during rotavirus morphogenesis.
MATERIALS AND METHODS
Cells and virus. A variant (clone 28) of the simian rotavirus SAil that contains nonglycosylated VP7 structural proteins was propagated at low multiplicity (0.1 PFU per cell) in MA104 monolayers as previously described (6) . A wild-type baculovirus (Autographa californica nuclear polyhedrosis virus [AcNPV] ) and baculovirus recombinants containing rotavirus genes (pVL941/Rf-1, pVL941/Rf-5, pAc461/SA11-6, pVL941/SA11-9, pAc461/SA11-10, and pVL941/SA11-11) were used to infect Spodoptera frugiperda (IPLB-SF21-AE [Sf9] ) cells at a multiplicity of infection of 10 PFU per cell. The selection of baculovirus recombinants containing rotavi-rus genes has been described previously (8a, 13, 51; M. K. Estes and J. Cohen, unpublished data). Sf9 cells were grown and maintained on Hink's medium containing 10% fetal bovine serum (46) .
Preparation of ligands for binding assays. In the description of our experiments, ligand refers to rotavirus ss particles. To prepare ss particles, confluent monolayers of MA104 cells were infected with trypsin-activated SAl virus at a high multiplicity of infection (20 to 30 PFU per cell) (6) . ss particles were metabolically labeled in Eagle minimal essential medium in the presence of 5 ,ug of actinomycin D (Pharmacia, Piscataway, N.J.) per ml with 3H-labeled amino acids (40 to 50 ,uCi/ml; 240 mCi/mg), Tran35S (20 ,uCi/ml; 1,200 Ci/mmol), or 32p; (150 ,uCi/ml; 260 mCi/ml) (all from ICN Radiochemicals, Irvine, Calif.) added at 3 h postinfection (p.i.). The ss particles were harvested at 6 to 7 h p.i. to generate optimal amounts of active ligands. ss particles were purified by two cycles of centrifugation in CsCl gradients and were analyzed for purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (31) . Particle counts were estimated by electron microscopy (37) .
Preparation of microsomes for binding assays. Microsomes were prepared by using a method modified from Gaetani et al. (17) . Briefly, MA104 monolayers were mock infected or were infected with SAl as described above. At 6 to 7 h p.i. the culture medium was removed, and monolayers were rinsed twice with ice-cold phosphate-buffered saline (0.01 M sodium phosphate buffer [pH 7.2], 0.14 M NaCl). Cells were detached by 0.7 mM EDTA in phosphate-buffered saline and were pelleted at 1,000 x g for 10 min at 4°C. After two washes with ice-cold 0.14 M NaCl, the cells were treated with 1 mM MgC12 and were incubated on ice until all cells were swollen when observed by phase-contrast microscopy. Swollen cells were homogenized with a Dounce type A pestle (Wheaton Industries, Millville, N.J.) for 30 to 40 strokes in an ice bath, and the nuclei and unbroken cells were pelleted at 5,000 x g for 10 min. The supernatant was collected and centrifuged at 20,000 x g for 30 min. The resulting pellet was suspended in 30% sucrose in binding buffer (buffer I: 50 mM Tris hydrochloride [pH 7.5], 50 mM KCl, 5 mM MgCI2, 1 mg of bovine serum albumin per ml, 1 mM dithiothreitol) and was layered on a discontinuous sucrose gradient (0.4 ml of 60% sucrose, 1.0 ml of 45% sucrose, 1.0 ml of 40% sucrose, 2.0 ml of 30% sucrose containing the suspended pellet, and 0.5 ml of 25% sucrose on top) in the same buffer in a polyallomer tube. After centrifugation at 190,000 x g for 2 h at 4°C, the 40 and 45% sucrose fractions were collected separately and were stored at -70°C in aliquots of 30% sucrose in buffer I for later binding assays. Microsomes from the 45% sucrose fraction contained the highest binding activity. The 260-and 280-nm absorbancies of the membrane preparations were determined, and 0.5 A260 unit was added to all standard binding assays.
Microsomes from Sf9 cells, infected either with a wildtype baculovirus (AcNPV) or with baculovirus recombinants, were harvested at 48 h p.i. and were prepared in the same way as those from MA104 cells. Dog pancreatic microsomes containing NS28 were prepared by using the rabbit reticulocyte lysate (RRL) in vitro translation system programmed with Sp6-G1O mRNA, as described by Mason et al. (31) and Ericson et al. (12) and modified as previously described (5) . These microsomes were collected by centrifugation at 14,000 x g at 4°C for 30 min and were suspended in buffer I for binding assays.
Assay After incubation at room temperature for 60 min, 0.5% Triton X-100 was added to dissolve the membranes. Proteins that had associated with the added viral particles were determined by analysis of the pellets obtained after centrifugation at 240,000 x g for 1 h through a 5 to 25% preformed sucrose gradient. The supernatant was carefully removed, the pellet was washed once with buffer I, and the washed pellet was suspended in 100 pd of buffer I for further analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Immunoprecipitation of NS28 was performed by using the procedure of Ericson et al. (11) . lodination of proteins. Membrane proteins were modified by enzymatic iodination with the Enzymobead reagent (BioRad Laboratories, Richmond, Calif.) using the protocol of the manufacturer. The reaction mixtures contained 300 ,ul of 0.2 M phosphate buffer (pH 7.2), 6 A260 units of microsomes, 300 pJ of Enzymobead reagent, 150 pul of 1% -D-glucose, and 30 pul of 10 mM nonradioactive NaL. Aliquots corresponding to 1 A260 unit of microsomes were harvested at different time points (0, 1, 5, 10, 20, and 40 min) by centrifugation for 30 s in a Microfuge to pellet the Enzymobeads, and the supematant was centrifuged in an airfuge at 27 lb/in2 for 15 min. Pellets of the iodinated microsomes were then used in the standard binding assay. Purified ss particles were treated similarly, except that the centrifugation step in the airfuge was omitted.
RESULTS
Development of an assay system to study the binding of SAll ss particles to microsomes from cultured cells. To test our hypothesis that rotavirus ss particles bind to the Cterminal cytoplasmic domain of NS28 in the ER membrane, we first developed an assay system to measure possible binding. A filtration method and a centrifugation method were initially compared for recovery of radiolabeled microsomes. More than 85% of the input count of Tran35S-labeled microsomes was recovered by the centrifugation method, as compared with recovery of 40 to 50% by the filtration method (data not shown). We next tested binding of radiolabeled (Tran35S, 32Pi, or 3H-labeled amino acid mixture) ligands (ss particles) to microsomes from SAl1-infected cells (IRM) and from noninfected cells (RM) using both the centrifugation and filtration methods. With each of the labeled ligands, greater binding was observed when the centrifugation method was used. Comparably high counts were bound using ligands labeled with 32p; (Fig. 1 ) or 3H-labeled amino acids (data not shown), and these counts were about 10 times greater than those bound using Tran35S-labeled ligands (data not shown). The centrifugation method and ligands labeled with 3H-labeled amino acids were used for the remainder of our experiments. Standard assay conditions were chosen to contain an amount (0.5 A260 unit) of infected cell microsomes that showed a reproducible and significant amount of radioactivity bound and also conserved the amount of microsomes needed per assay. In different assays, from 10 to 20% of the input cpm (7 x 107 3H-labeled ss particles) was bound to 0.5 A260 units of SAl1-infected cell microsomes; the variation in binding was due to the use of different batches of radiolabeled ligands and microsome preparations in different experiments. Similarly, approximately 2 to 4% of input cpm was bound to microsomes from mock-infected MA104 cells. 3A) . In contrast, microsomes from wild-type baculovirus (AcNPV)-infected cells showed low and nonspecific binding with SAl ss particles. This result strongly suggests that NS28 alone functions as a receptor for ss particle binding. To confirm that NS28 alone was sufficient to provide the receptor activity, we tested the ability of microsomes isolated from insect cells infected with recombinant baculoviruses containing other rotavirus genes to bind radiolabeled ss particles (Fig. 4) Scatchard analysis of the data from the microsomes from pAc461/SA11-10-infected Sf9 cells showed a nearly linear plot (Fig. 3B) . The binding constant (Kd) of the receptor in the Sf9 cell ER membranes was calculated to be 2.3 pM. The estimated number of receptor sites on the Sf9 cell microsomes was 7.2 x 108 per A260 unit of Sf9 cell microsomes.
Protease treatment removes the specific binding activity of IRM. Our hypothesis that the cytoplasmic domain of NS28 acts as a receptor (5, 11, 38) (Fig. 7) . These data are consistent with and 255/oO, respectively) both competed significantly with that one or both tyrosine residues may play a critical ligand (Fig. 9) . However, even at high concentrations (5 antibody (2C2) and a nonneutralizing monoclonal antibody to VP7 (monoclonal antibody 60) did not significantly affect binding (data not shown). An antiserum against SAl1 ds particles (which contained antibodies to VP1, VP2, VP3, VP4, VP6, and VP7) significantly reduced ligand binding to IRM, even at a low antibody concentration (data not shown).
Modification of ss particles by reaction with the Enzymobead reagent also resulted in a significant reduction of binding to infected cell microsomes as compared with binding of mock-iodinated particles (Fig. 10) . Binding was reduced by 50% after a brief (5-to 10-min) iodination reaction. However, background levels of bound counts per minute were not achieved even after 80 min of treatment.
DISCUSSION
The results of the experiments reported here support the hypothesis that rotavirus nonstructural glycoprotein NS28 functions as a receptor to bind subviral ss particles prior to particle budding through the ER membrane. Specific binding activity was observed between purified simian rotavirus SAl ss particles and RER membranes from SAl1-infected monkey kidney cells, from SAl1 gene 10 baculovirus recombinant-infected insect cells, and from RRL programmed with SAl gene 10 mRNA and supplemented with microsomes.
Several properties of NS28 as a receptor are noteworthy. Comparison of the binding data using Scatchard analysis showed a concave plot for microsomes from SAl1-infected cells and a linear plot for microsomes containing NS28 from insect cells. Curved Scatchard plots generally indicate the presence of multiple ligand-multiple receptor interactions (16, 20, 21, 25, 30, 32 (5), one or both of these residues may be important in binding activity.
Finally, our observation that proteolytic digestion of the microsomes reduces ss particle binding activity also implicates the cytoplasmic region of NS28 in binding. We have previously shown that digestion with trypsin or proteinase K removes the cytoplasmic domain of NS28, leaving an -18,000-Mr glycosylated polypeptide (amino acid residues -1 to 86 [5] ). Consistent with this observation, removal of the cytoplasmic domain abolished ligand-binding activity. In contrast, chymotrypsin cleavage, which produces an -23,000-Mr glycosylated polypeptide containing only half of the cytoplasmic domain of NS28 (amino acids -86 to 131), resulted in low but consistent ligand-binding activity; this suggests that another receptor site may be located between amino acid residues 86 and 131. The possibility that the residual binding activity was due to incomplete digestion of NS28 seems unlikely (5) . Oligopeptides spanning different regions of NS28 may be useful reagents for competition experiments to elucidate the active site for ss particle binding. Moreover, further characterization of particle binding with additional mutated forms of NS28 will help to precisely locate the receptor site on NS28.
Natural variation in the amino acid sequences of NS28 of different rotavirus strains permitted us to examine possible binding by a completely different approach. One third of the variable amino acids found by comparison of the deduced amino acid sequences of NS28 of different rotavirus strains (human WA, bovine UK and NCDV, and simian SAil) has been found to be localized in the region between amino acid residues 131 and 141 (34, 39, 50 Identification of the specific ligand on particles that binds to NS28 was examined by testing the reduction of binding of ss particles following reactivity with antibodies to specific rotavirus proteins. First, it should be noted that high background binding to microsomes from mock-infected cells was observed in all experiments. This may be because VP6 is myristylated and lipophilic (8) . The antibody competition experiments suggest that VP6 (the major capsid protein on ss particles) is involved in the binding and that the subgroup epitope may be part of the active binding site. However, this hypothesis needs further analysis because particle binding was not completely reduced to background levels and steric effects of bound antibody blocking the active site cannot be ruled out. The augmentation of particle binding after reactivity with the monoclonal antibody (631/7) to a common epitope of VP6 suggests that the binding site may be partially buried normally but becomes exposed by conformational changes after binding of this monoclonal antibody.
Our present results also cannot rule out the participation of other viral proteins acting in concert with VP6 during binding of subviral particles. Polyclonal antiserum to ds particles blocked binding significantly (data not shown); thus, testing the effects of antisera against individual viral structural proteins would be a useful approach to determine if another protein(s) interacts with NS28. Unfortunately, high-titered monospecific antisera against VP1, VP2, VP3, and VP4 are not currently available to determine whether these proteins are involved in binding. Our finding of background binding with microsomes from Sf9 cells expressing VP1, VP4, NS53, VP6, VP7, and the gene 11 product NS26 suggests that none of these viral proteins functions as a receptor, but our results do not exclude the possibility that they participate in or enhance the binding process. Our use of the SAll variant that produces a nonglycosylated VP7 indicates that glycosylation of VP7 is not necessary for binding to occur. Further use of the in vitro binding system described here should allow the role of each protein to be evaluated.
Our demonstration of specific binding between ss particles and NS28 also addresses the question of whether ss particles are true intermediates in the virus morphogenic process or whether they are dead-end products. There has been controversy as to whether rotavirus ss particles are intermediate particles in replication (28, 42) . Our results support the hypothesis that ss particles are the precursors of ds particles in rotavirus replication. We hypothesize that the subviral particles after binding to NS28 become committed to budding and envelopment. The rotavirus morphogenic process contains additional unique and complicated steps as compared with those for enveloped viruses. For example, the envelope obtained during budding is transient and, as it is obtained or removed, the outer capsid proteins (VP4 and VP7) are assembled onto the ds particles by a currently unknown mechanism(s). Immunoelectron microscopy has detected VP4 in the spaces between the viroplasm and the RER (38) , whereas VP7 is known to be inserted into the lumen of the ER where it remains associated with the membrane, also by an unknown mechanism(s). One suggested mechanism for the retention of VP7 in the RER lumen is by the interaction between the cleaved signal peptide and the other VP7 downstream amino acids (48 
